Rafael Moreschi
Internal Medicine · Cary, NCNPI 1962412213
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 97.1% of the total across 219 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. It is spread thinly across 23 manufacturers, the largest accounting for just 16.5% — the pattern of someone who eats at a lot of different presentations. Reporting peaked in 2021 at $1,177 and has fallen 92.2% since, to $92 in 2023.
Across 219 payments — averaging $17.44 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AstraZeneca$631
- Amarin Pharma, Inc.$565
- Novo Nordisk$534
- Boehringer Ingelheim$437
- Novartis$228
- Kowa Pharmaceuticals America, Inc.$188
- plus $1K from 17 others
What the payments were for
- Food & beverage$3,70797%
- Education$1123%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| AstraZeneca | 37 | $631 |
| Amarin Pharma, Inc. | 22 | $565 |
| Novo Nordisk | 43 | $534 |
| Boehringer Ingelheim | 25 | $437 |
| Novartis | 10 | $228 |
| Kowa Pharmaceuticals America, Inc. | 13 | $188 |
| Astellas Pharma US Inc | 4 | $170 |
| Johnson & Johnson | 9 | $127 |
| Merck | 10 | $126 |
| Amgen | 7 | $103 |
| Pfizer | 7 | $103 |
| Lilly USA, LLC | 3 | $98 |
| Regeneron Healthcare Solutions, Inc. | 7 | $97 |
| Nestle Healthcare Nutrition Inc. | 4 | $76 |
| E.r. Squibb & Sons, L.L.C. | 5 | $75 |
| Insulet Corporation | 1 | $49 |
| AbbVie | 2 | $39 |
| Arbor Pharmaceuticals, Inc. | 2 | $39 |
| Phadia US Inc. | 2 | $33 |
| Sanofi-aventis U.S. LLC | 2 | $33 |
| Esperion Therapeutics, Inc. | 2 | $26 |
| Eisai Inc. | 1 | $22 |
| Edwards Lifesciences | 1 | $20 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$3,820 in reported general payments places this provider in the 85th percentile of 3,302 internal medicine providers in North Carolina.
Other internal medicine in Cary
- Jennings DawkinsCary$109K
- Nirmish ShahDurham$862K
- Eugene WrightFayetteville$839K
- Saad UsmaniCharlotte$551K
- Bhakti PaulRaleigh$536K
- Mary KlotmanDurham$478K
- Manesh PatelDurham$435K
- Millie LongChapel Hill$374K
- Marc JohnsonCharlotte$342K
- Christina CraterRaleigh$330K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.